Target  	Target  	 NN	B-NP
analysis  	analysis  	 NN	I-NP
and  	and  	 CC	O
retrospective  	retrospective  	 JJ	B-NP
screening  	screening  	 NN	I-NP
of  	of  	 IN	I-NP
veterinary  	veterinary  	 JJ	I-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
ergot  	ergot  	 JJ	B-NP
alkaloids 	alkaloids 	 NN	I-NP
,  	,  	 ,	O
plant  	plant  	 NN	O
toxins  	toxins  	 NNS	O
and  	and  	 CC	O
other  	other  	 JJ	O
undesirable  	undesirable  	 JJ	O
substances  	substances  	 NNS	O
in  	in  	 IN	O
feed  	feed  	 NN	O
using  	using  	 VBG	O
liquid  	liquid  	 JJ	B-NP
chromatography-high  	chromatography-high  	 JJ	I-NP
resolution  	resolution  	 NN	I-NP
mass  	mass  	 NN	I-NP
spectrometry  	spectrometry  	 VBD	O
A  	A  	 DT	O
comprehensive  	comprehensive  	 JJ	B-NP
strategy  	strategy  	 NN	I-NP
combining  	combining  	 VBG	O
a  	a  	 DT	O
quantitative  	quantitative  	 JJ	B-NP
method  	method  	 NN	I-NP
for  	for  	 IN	O
77  	77  	 CD	O
banned  	banned  	 VBN	O
veterinary  	veterinary  	 JJ	B-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
mycotoxins 	mycotoxins 	 NN	B-NP
,  	,  	 ,	O
ergot  	ergot  	 JJ	B-NP
alkaloids  	alkaloids  	 NN	I-NP
and  	and  	 CC	O
plant  	plant  	 NN	O
toxins 	toxins 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
post-target  	post-target  	 JJ	B-NP
screening  	screening  	 NN	I-NP
for  	for  	 IN	O
425  	425  	 CD	O
substances  	substances  	 NNS	O
including  	including  	 VBG	B-NP
pesticides  	pesticides  	 NNS	I-NP
and  	and  	 CC	O
environmental  	environmental  	 JJ	B-NP
contaminants  	contaminants  	 NN	I-NP
in  	in  	 IN	O
feed  	feed  	 NN	O
were  	were  	 VBD	O
developed  	developed  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
QuEChERS-based  	QuEChERS-based  	 JJ	O
extraction  	extraction  	 NN	O
and  	and  	 CC	O
an  	an  	 DT	O
ultra-high  	ultra-high  	 JJ	B-NP
performance  	performance  	 NN	I-NP
liquid  	liquid  	 NN	I-NP
chromatography  	chromatography  	 VBZ	I-NP
coupled  	coupled  	 VBN	I-NP
to  	to  	 TO	I-NP
high-resolution  	high-resolution  	 JJ	I-NP
mass  	mass  	 NN	I-NP
spectrometry  	spectrometry  	 NNS	I-NP
( 	( 	 -LRB-	O
UHPLC-HRMS 	UHPLC-HRMS 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
quantitative  	quantitative  	 JJ	B-NP
method  	method  	 NN	I-NP
was  	was  	 VBD	O
validated  	validated  	 VBN	O
after  	after  	 IN	O
previous  	previous  	 JJ	O
statistical  	statistical  	 JJ	B-NP
optimisation  	optimisation  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
main  	main  	 JJ	O
parameters  	parameters  	 NNS	O
governing  	governing  	 VBG	B-NP
ionisation 	ionisation 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
presented  	presented  	 VBN	B-NP
recoveries  	recoveries  	 NNS	I-NP
ranging 	ranging 	 VBG	O
,  	,  	 ,	O
in  	in  	 IN	O
general 	general 	 JJ	O
,  	,  	 ,	O
from  	from  	 IN	O
80  	80  	 CD	O
to  	to  	 TO	O
120 	120 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
with  	with  	 IN	O
a  	a  	 DT	O
precision  	precision  	 NN	O
in  	in  	 IN	O
terms  	terms  	 NNS	O
of  	of  	 IN	O
Relative  	Relative  	 NNP	B-NP
Standard  	Standard  	 NNP	I-NP
Deviation  	Deviation  	 NNP	I-NP
( 	( 	 -LRB-	O
RSD 	RSD 	 NNP	B-NP
)  	)  	 -RRB-	O
lower  	lower  	 JJR	O
than  	than  	 IN	O
20 	20 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
full-scan  	full-scan  	 JJ	O
accurate  	accurate  	 JJ	O
mass  	mass  	 NN	B-NP
data  	data  	 NNS	I-NP
were  	were  	 VBD	O
acquired  	acquired  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
resolving  	resolving  	 JJ	O
power  	power  	 NN	O
of  	of  	 IN	O
50000  	50000  	 CD	O
FWHM  	FWHM  	 NNP	B-NP
and  	and  	 CC	O
a  	a  	 DT	O
mass  	mass  	 JJ	B-NP
accuracy  	accuracy  	 NN	I-NP
lower  	lower  	 JJR	O
than  	than  	 IN	O
5ppm 	5ppm 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
method  	method  	 NN	B-NP
LOQ  	LOQ  	 NNP	I-NP
was  	was  	 VBD	O
lower  	lower  	 JJR	O
than  	than  	 IN	O
12.5µgkg 	12.5µgkg 	 NNP	O
( 	( 	 -LRB-	O
-1 	-1 	 NNP	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
the  	the  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
veterinary  	veterinary  	 JJ	B-NP
drugs  	drugs  	 NNS	I-NP
and  	and  	 CC	O
plant  	plant  	 NN	O
toxins  	toxins  	 NNS	O
and  	and  	 CC	O
20µgkg 	20µgkg 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
-1 	-1 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
for  	for  	 IN	I-NP
ergot  	ergot  	 JJ	I-NP
alkaloids 	alkaloids 	 NN	I-NP
.  	.  	 .	O
For  	For  	 IN	O
post-target  	post-target  	 JJ	B-NP
screening  	screening  	 VBG	O
a  	a  	 DT	O
customised  	customised  	 JJ	B-NP
theoretical  	theoretical  	 JJ	I-NP
database  	database  	 NN	I-NP
including  	including  	 VBG	O
the  	the  	 DT	O
exact  	exact  	 JJ	O
mass 	mass 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
polarity  	polarity  	 NN	O
of  	of  	 IN	O
acquisition  	acquisition  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
expected  	expected  	 JJ	O
adducts  	adducts  	 NN	B-NP
was  	was  	 VBD	O
built  	built  	 VBN	O
and  	and  	 CC	O
used  	used  	 VBN	O
for  	for  	 IN	O
post-run  	post-run  	 JJ	B-NP
retrospective  	retrospective  	 JJ	I-NP
screening 	screening 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
analytical  	analytical  	 JJ	B-NP
strategy  	strategy  	 NN	I-NP
was  	was  	 VBD	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
32  	32  	 CD	O
feed  	feed  	 NN	O
samples  	samples  	 NNS	O
collected  	collected  	 VBN	O
from  	from  	 IN	O
farms  	farms  	 NNS	O
of  	of  	 IN	O
the  	the  	 DT	O
Valencia  	Valencia  	 NNP	O
Region  	Region  	 NNP	O
( 	( 	 -LRB-	O
Spain 	Spain 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Florfenicol 	Florfenicol 	 NNP	B-NP
,  	,  	 ,	O
zearalenone  	zearalenone  	 NN	B-NP
and  	and  	 CC	O
atropine  	atropine  	 NNS	B-NP
were  	were  	 VBD	O
identified  	identified  	 VBN	O
and  	and  	 CC	O
quantified  	quantified  	 VBN	O
at  	at  	 IN	O
concentrations  	concentrations  	 NNS	B-NP
around  	around  	 IN	O
10µgkg 	10µgkg 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
-1 	-1 	 NNP	I-NP
) 	) 	 -RRB-	I-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
post-target  	post-target  	 JJ	B-NP
screening  	screening  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
real  	real  	 JJ	O
samples 	samples 	 NNS	O
,  	,  	 ,	O
Sulfadiazine 	Sulfadiazine 	 NNP	B-NP
,  	,  	 ,	O
Thrimetoprin  	Thrimetoprin  	 NNP	B-NP
and  	and  	 CC	O
Pirimiphosmethyl  	Pirimiphosmethyl  	 NNP	B-NP
were  	were  	 VBD	O
tentatively  	tentatively  	 RB	O
identified 	identified 	 VBN	O
.  	.  	 .	O
